Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer
Conditions: HER2-negative Breast Cancer; Inflammatory Breast Cancer; Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast CancerInterventions: Drug: Romidepsin; Drug: AbraxaneSponsors: Thomas Jefferson University; Celgene CorporationRecruiting - verified May 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Abraxane | Breast Cancer | Cancer | Cancer & Oncology | HER2 | Inflammatory Breast Cancer | Research